Your browser doesn't support javascript.
loading
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.
Huang, Raymond Y; Rahman, Rifaquat; Ballman, Karla V; Felten, Sara J; Anderson, S Keith; Ellingson, Benjamin M; Nayak, Lakshmi; Lee, Eudocia Q; Abrey, Lauren E; Galanis, Evanthia; Reardon, David A; Pope, Whitney B; Cloughesy, Timothy F; Wen, Patrick Y.
Afiliación
  • Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts. Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. ryhuang@partners.org.
  • Rahman R; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Ballman KV; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Felten SJ; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Anderson SK; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Ellingson BM; Departments of Radiological Sciences and Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California.
  • Nayak L; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Lee EQ; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Abrey LE; F. Hoffmann-La Roche Ltd, Pharmaceuticals Division, Product Development Oncology, Basel, Switzerland.
  • Galanis E; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Reardon DA; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Pope WB; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Cloughesy TF; Departments of Neurology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California.
  • Wen PY; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
Clin Cancer Res ; 22(3): 575-81, 2016 Feb 01.
Article en En | MEDLINE | ID: mdl-26490307
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Neoplasias Encefálicas / Glioblastoma / Inhibidores de la Angiogénesis / Bevacizumab / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Neoplasias Encefálicas / Glioblastoma / Inhibidores de la Angiogénesis / Bevacizumab / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article